Short description
BioLoomics is a biotechnology company that develops antibodies for cancer therapies.
Description
BioLoomics is a biotechnology company that uses directed evolution to develop antibodies with programmable spatial fate in target cells.
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Boulder, Colorado, United States, North America
Founded on
January 1, 2019
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noway Youcantaccess, Noway Youcantaccess, Blurry Noaccess, No Way, No Way, Noway Youcantaccess, Noaccess, Absolutely Noaccess, No Way
Sign in for full access
Founders
Doug Chapnick